Listed

Kraig Biocraft Laboratories, Inc.: Form 10-Q for the period ended Mar 31, 2015

Filed with the SEC on May 11, 2015 and accepted by EDGAR at May 11, 2015, 16:27 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-01-01 to 2015-03-31$0us-gaap:SalesRevenueNet
Research and development3 months2015-01-01 to 2015-03-31$79.6kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2015-01-01 to 2015-03-31−$404.0kus-gaap:OperatingIncomeLoss
Interest expense3 months2015-01-01 to 2015-03-31$21.9kus-gaap:InterestExpense
Income tax3 months2015-01-01 to 2015-03-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-01-01 to 2015-03-31−$416.2kus-gaap:NetIncomeLoss
Diluted EPS3 months2015-01-01 to 2015-03-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2015-01-01 to 2015-03-31−$206.5kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2015-01-01 to 2015-03-31$39.3kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-03-31$249.3kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-03-31$250.3kus-gaap:AssetsCurrent
Total assetsAt period end2015-03-31$330.1kus-gaap:Assets
Current liabilitiesAt period end2015-03-31$1.9mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2015-03-31−$1.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001354488-15-002264. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.